Introduction
Gastrointestinal (GI) motility is controlled by the enteric nervous system that innervates both the smooth muscle cells and interstitial cells of Cajal (ICC). Smooth muscle cells from the lower esophagus to the rectum form two main muscle layers, the circular muscle layer and longitudinal muscle layer. ICC are nonmuscle mesenchymal cells that develop from the same progenitors of smooth muscle cells (Sanders, 1996; Rumessen and Vanderwinden, 2003) . ICC act as both pacemakers in generating intestinal slow waves and intermediates in neuro-muscular transmission. ICC can be observed immunohistochemically using c-Kit antibodies and are classified as follows: intramuscular ICC (ICC-IM), ICC in the deep muscular plexus layer (ICC-DMP), ICC in the myenteric layer (ICC-MY), ICC in the submucosal surface of the circular muscle layer (ICC-SM), and ICC in the subserosal layer (ICC-SS) (Sanders, 1996; Rumessen and Vanderwinden, 2003; Iino and Horiguchi, 2006) . Another type of mesenchymal cell, the fibroblast-like cell (FLC), has been reported in the GI musculature by immunohistochemical or electron microscopic observations (Komuro et al., 1999;  suffering. All the mice were anesthetized with ether and the GI tracts were excised.
To generate an SK3-specific polyclonal antibody, a peptide corresponding to residues 2-17 of mouse/ r a t / h u m a n S K 3 , D T S G H F H D S G V G D L D C , w a s synthesized and coupled to keyhole limpet hemocyanin (Invitrogen, Japan). Polyclonal antibodies were prepared by immunizing female New Zealand White rabbits (KITAYAMA LABES, Ina, Nagano). The specific peptide antibody (SR8) was obtained by affinity chromatography using the appropriate peptide immobilized on formilc e l l u l o f i n e ( S e i k a g a k u C o r p o r a t i o n , T o k y o ) . T o specify the immunoreactivity of SR8, the antibody was preabsorbed by the synthesized peptide.
For cryostat studies, the GI tract was flushed with 0.01 M phosphate buffered saline (PBS), pH 7.2 before being pinned to the Sylgard elastomer (Dow Corning Co., USA) floor of a dissecting dish. It was then fixed with Zamboni's fixative [2% paraformaldehyde made in 1.5% saturated picric acid solution, 0.1M phosphate buffer, (pH 7.3)] for 2 h at room temperature. Following fixation, the tissues were washed with PBS, immersed in 30% sucrose containing PBS, and embedded in OCT compound (Sakura Finetek, Tokyo). Cryostat sections were cut at a thickness of 12 m using a Leica CM3050 cryostat (Leica Microsystems, Germany) and collected on poly-L-lysine-coated glass slides. Sections were preincubated with normal donkey serum (5% in PBS) for 1 h before being incubated with the following antibodies at room temperature: rabbit anti-SK3 (SR8; 1:1500), rat anti-c-Kit (ACK4; Acris antibodies, Germany; 1:700), rat anti-PDGFR (APA5; eBioscience, USA; 1:700), rat anti-CD34 (RAM34; eBioscience; 1:800), and sheep anti-protein gene product 9.5 (PGP9.5; GTX74292, Gene Tex, USA; 1:2000). After the sections were incubated overnight with the primary antibodies, they were washed with PBS before being incubated with the secondary antibody (Alexa Fluor-coupled donkey antiIgG, Molecular Probes, USA; 1:500) for 1 h at room temperature. After washing with PBS, the specimens were counter-stained with 4 ,6-diamidino-2-phenylindole (DAPI; Molecular Probes) and mounted in Mowiol solution (Mowiol 4-88, EMD Bioscience, USA).
For whole-mount preparations, tissues were placed in and flushed with PBS, and then pinned to a dissecting dish and stretched to 150% of their resting length before being fixed in ice-cold acetone for 15 min. The tissues were washed with PBS and the mucosa was removed by sharp dissection. The tissues were washed with PBS containing 0.3% Triton X-100 (PBST) for 1 h. After incubation in normal donkey serum (5% in PBST) for 1 h, the tissues were incubated with rabbit anti-SK3 and rat anti-c- Rumessen and Vanderwinden, 2003) .
FLC have been extensively studied by electron microscopy (Reviewed by Komuro et al., 1999) . FLC have well-developed rough endoplasmic reticulum, often with dilated cisterns, Golgi apparatus, and mitochondria around the nucleus. Gap junctions are frequently observed between FLC or with smooth muscle cells. FLC are found everywhere on the GI musculature with almost uniform ultrastructural characters unrelated to the region of the GI tract. Molecular expressions of FLC in the GI musculature have been reported previously and are known as CD34, small conductance Ca 2+ -activated K + channel 3 (SK3), and platelet-derived growth factor receptor (PDGFR ). CD34 was first reported to be immunohistochemically expressed in the human FLC, but was barely detected in the murine FLC (Vanderwinden et al., 1999 (Vanderwinden et al., , 2000 (Vanderwinden et al., , 2002 . SK3 immunoreactivity has been reported in human and murine FLC (Vanderwinden et al., 2002; Fujita et al., 2003) although some reports showed the expression of SK3 immunoreactivity in ICC of several species (Fujita et al., 2001; Klemm and Lang, 2002; Piotrowska et al., 2003) or in smooth muscle cells of the murine GI tract (Ro et al., 2001) . We recently showed that PDGFR immunoreactivity was specifically distributed in FLC in the murine GI musculature and was co-localized with SK3 (Iino et al., 2009a) . From our previous study, we found that FLC having PDGFR immunoreactivity are morphologically similar to but different from ICC. We also observed that FLC in the musculature differed from the submucosal fibroblasts that lacked PDGFR immunoreactivity in the submucosal connective tissue. Thus, to elucidate the immunochemical features of FLC in the murine GI musculature, we immunohistochemically examined FLC using an SK3 antibody and analyzed the immunohistochemical co-distribution of PDGFR and CD34.
Materials and Methods
BALB/c and C57BL/6-W v /+ mice were purchased from Japan SLC (Hamamatsu) and maintained in our laboratory. C57BL/6-W v /W v and C57BL/6-+/+ mice were obtained by crossing the C57BL/6-W v /+ parents (Iino et al., 2007) . Since the same results were obtained from the BALB/c and C57BL/6-+/+ mice, we used the BALB/c mice data in this report. All the experiments were conducted in mice aged between eight and twelve weeks. The use and treatment of the animals was in accordance with the Guidelines for Animal Experiments, University of Fukui Faculty of Medical Sciences. Every effort was made to minimize the number of animals used and their and concluded that SK3-ip cells were different from ICC. The SK3-ip cells were often observed in the proximity of c-Kit-ip ICC. The SK3-ip cells in the muscular layer were usually deployed along enteric nerve fibers that were immunolabeled by pan-neuronal marker PGP9.5 (Fig. 4) . The SK3-ip cells in the myenteric layer were often located around the myenteric ganglia (Fig. 4) .
In the fundus and corpus of the stomach, SK3-ip cells were observed in the circular and longitudinal muscle layers, myenteric layer, and subserosal layer ( Fig. 2A , B, 3A -C). SK3-ip cells displayed a bipolar slender shape with long thin processes along the smooth muscle cells in the circular and longitudinal muscle layers. SK3-ip cells in the myenteric layer exhibited a multipolar shape with three or four processes from the round or oval cell bodies.
Kit antibodies diluted with PBST for 36 h at 4 . The tissues were then incubated in the secondary antibodies (Alexa Fluor-coupled donkey anti-IgG, 1:500 in PBST) for 1 h at room temperature. After washing with PBS, the specimens were mounted on glass slides with Mowiol solution.
Fluorescent images were examined with a Leica TCS-SP2 confocal microscope (Leica Microsystems) with excitation wavelengths of 350 nm, 488 nm, and 543 nm. Images were collected and composed using Leica Confocal Software (Leica Microsystems). Some of the confocal micrographs are digital composites of several Z-series optical sections through the partial thickness of the musculature. Adobe Photoshop CS2 (Adobe Systems, USA) was used to compose the final plates.
F o r i m m u n o b l o t a n a l y s i s , t h e s u p e r n a t a n t s o f homogenates from musculatures of murine small intestines were separated by sodium dodecyl sulfatep o l y a c r y l a m i d e g e l e l e c t r o p h o r e s i s u s i n g a 1 0 % polyacrylamide gel and transferred to a membrane (Immobilon-P, Millipore Co., USA). Membranes were blocked with 5% fat-free dry milk in PBS containing 0.05% Tween-20 and then incubated with rabbit anti-SK3 antibody (1:2000). Immune complexes were visualized using a chemiluminescence system (ECL Plus, GE Healthcare UK Ltd., England) with HRP-conjugated antirabbit IgG.
Results
We generated antibodies by immunizing rabbits and purifying specific antibodies using an SK3 peptideimmobilized column. In this study, we used the anti-SK3 antibody named SR8 for immunohistochemical analysis following the specificity check. In the immunoblot analysis of the small intestinal musculature, the anti-SK3 antibody recognized a single band of an expected size, approximately 80 kDa (Fig. 1A) . The anti-SK3 antibody preabsorbed with the immunizing SK3 peptide abolished the immunoreactive band (Fig. 1B) . The anti-SK3 antibody also recognized specific immunopositive cells throughout the GI musculature (Fig. 1B) . After antibody absorption using an immunizing peptide, SK3-immunopositive (ip) cells were not observed.
SK3-ip cells were observed in the circular and longitudinal muscle layers, myenteric layer, and subserosal layer in the murine GI musculature. Since S K 3 -i p c e l l s s h o w e d f i b r o b l a s t -l i k e o r I C C -l i k e morphology, we used double immunohistochemistry with SK3 and c-Kit antibodies (Fig. 2, 3) . We observed all SK3-ip cells as negative for c-Kit immunoreactivity No specific immunoreactive band of SK3 is detected after antibody absorption using a specific immunogen (lane 2). Molecular markers (kDa) are shown on the left. B: Immunohistochemical analysis of SK3 expression in the small intestine. The SK3 antibody (SR8) detects specific immunopositive cells (arrowheads) in the musculature (B1). The SK3 immunoreactivity is not observed after antibody absorption using a specific immunogen (B2). B1' and B2' show differential interference contrast images of B1 and B2. CM: circular muscle, LM: longitudinal muscle. Bars: 20 m multipolar SK3-ip cells were located adjacent to c-Kitip ICC-MY and formed a cellular network. There were numerous SK3-ip cells in the subserosal layer, where SK3-ip cells formed a cellular network with their long thin processes. In the cecum (Fig. 2D) and colon (Fig.  2E , F, 3H -J), SK3-ip cells were located in the circular muscle layer, myenteric layer, longitudinal muscle layer, and subserosal layer. In the muscle layers, bipolar cells with slender cell bodies and long processes had small spine-like protrusions from cell bodies and processes. SK3-ip cells in the myenteric layer exhibited wide cell These cells formed cellular networks with their ramified processes. SK3-ip cells and ICC-MY formed cellular networks independent of each other in the myenteric layer. Numerous SK3-ip cells were present along the serous membrane. These cells showed a flattened stellate shape with several processes. In the small intestine (Fig.  2C, 3D -G) , SK3-ip cells were located in the circular muscle layer, myenteric layer, and subserosal layer. SK3-ip cells in the circular muscle layer were bipolar in shape. In the DMP layer of circular muscle, ICC-DMP were associated with SK3-ip cells. In the myenteric layer, S i n c e w e h a v e p r e v i o u s l y r e p o r t e d t h a t F L C specifically expressed PDGFR immunoreactivity ( I i n o e t a l . , 2 0 0 9 a ) , w e p e r f o r m e d d o u b l e immunohistochemistry using SK3 and PDGFR antibodies (Fig. 5) . All SK3-ip cells examined in this study showed PDGFR immunoreactivity throughout the murine GI tract. In the submucosal tissue, several cells thought to be fibroblasts in the connective tissue bodies with many short processes and formed cellular networks. In the subserosal layer, there were multipolar SK3-ip cells with several long processes and a few c-Kitip ICC-SS. The long processes of SK3-ip cells extended longitudinally and made contact with adjacent SK3-ip cells. W v /W v mutant mice that are deficient in ICC (Iino et al., 2007) had intense SK3 immunoreactivity throughout the GI musculature (Fig. 2G -I) . The number and morphology of SK3-ip cells in W v /W v mice were similar to 
slender SK3-ip cells (arrowheads) intermingle with ICC-IM (red) in the circular muscle layer (A). Multipolar SK3-ip cells (arrows) are observed close to ICC-MY (red) at the myenteric layer (B). Highly branched multipolar SK3-ip cells at the subserosal layer (C). D-G: In the ileum, SK3-ip cells are observed in the circular muscle layer (D, E), myenteric layer (F), and subserosal layer (G). In the circular muscle layer, SK3-ip cells (arrowheads) are associated with (D) or without (E) ICC-DMP (red). SK3-ip cells in the myenteric and subserosal layers show a multipolar shape. H-J:
In the distal colon, there are SK3-ip cells in the circular muscle layer (H), myenteric layer (I), and subserosal layer (J). Bar: 50 m cells in the muscle and myenteric layers expressed no CD34 immunoreactivity. Some SK3-ip cells had weak CD34 immunoreactivity. Intense CD34 immunoreactivity in the musculature was observed in the capillary endothelium, as reported previously (Vanderwinden et al., 2000) . The Serosal mesothelium that constitute the outermost thin layer of the GI tract showed distinct showed weak PDGFR immunoreactivity but no SK3 immunoreactivity. Since CD34 is a marker of FLC in the human GI musculature (Vanderwinden et al., 1999) , we examined CD34 immunoreactivity in murine GI musculature (Fig.  6) . Although SK3-ip cells in the subserosal layer often showed distinct CD34 immunoreactivity, most SK3-ip 
Discussion
In this study, we examined SK3 immunoreactivity in the murine GI musculature and found cells that had distinctive morphological features different from c-Kit-ip ICC. Our previous study showed PDGFR immunoreactivity in FLC and the co-localization of PDGFR and SK3 immunoreactivities in the murine GI tract (Iino et al., 2009a) . Vanderwinden et al. (2002) and Fujita et al. (2003) showed that SK3 immunoreactivity was preferentially distributed in c-Kit-immunonegative FLC in human and murine GI tracts. From these findings, we postulated that FLC in murine GI musculature possessed SK3 immunoreactivity. Although Fujita et al. (2003) concluded that SK3 immunoreactivity was distributed in c-Kit-immunonegative FLC, their group previously reported SK3 immunoreactivity in c-Kitip ICC in the rat GI tract (Fujita et al., 2001 ). Klemm and Lang (2002) also detected SK3 immunoreactivity in c-Kit-immunonegative cells and in a small number of c-Kit-ip cells in the guinea pig GI tract. Pitrowska et al. (2003) showed the coexpression of SK3 and c-Kit immunoreactivities in the human colonic ICC. Ro et al. (2001) reported the expression of SK3 immunoreactivity in the myenteric ganglia, nerve bundles, and smooth muscle cells in the murine jejunum and colon. The above-mentioned studies as well as our previous one were conducted using the SK3 antibody purchased from the same company (Alomone Labs, Ltd., Israel). Here we generated a specific SK3 antibody using peptide antigen and peptide affinity column and clarified the SK3 expression in murine FLC. Our results confirmed the previous results by Vanderwinden et al. (2002) and Fujita et al. (2003) that SK3 immunoreactivity was distributed in c-Kit-immunonegative FLC in the murine GI musculature.
FLC in the GI musculature have been studied by electron microscopy and been suggested to be a type of fibroblast (Komuro et al., 1999) . Immunohistochemical studies using the antibody against the collagen synthesis enzyme prolyl 4-hydroxylase revealed that FLC could potentially produce collagen fibers as a fibroblast function (Vanderwinden et al., 2002; Fujita et al., 2003) . PDGFR expression of FLC also suggests that FLC are a type of fibroblast because many fibroblasts in organs such as the heart, lung, and dermis express PDGFR (Andrae et al., 2008) . However, along with previous researchers, we did not detect SK3-ip cells in the submucosal connective tissue that contained numerous fibroblasts in the GI tract. Since fibroblasts in various tissues have not been reported to express SK3 immunoreactivity, FLC having SK3 immunoreactivity in GI musculature are considered different from commonly observed fibroblasts. In the human GI tract, FLC have been shown to express SK3 and CD34 immunoreactivities (Vanderwinden et al., 1999) . On the other hand, in the murine GI tract, almost all FLC have been detected specifically by an SK3 antibody and only a few FLC expressed CD34 immunoreactivity (Vanderwinden et al., 2000) . Although we found that FLC in the subserosal layer exhibited intense SK3 and CD34 immunoreactivities, almost all FLC in the muscular and myenteric layers showed no CD34 immunoreactivity and only a few SK3-ip FLC showed weak CD34 immunoreactivity. Fibroblasts in the submucosal tissue were observed to express intense CD34 immunoreactivity, as described previously (Vanderwinden et al., 2000) . From our immunohistochemical results, in conjunction with those from other previous reports, we conclude that SK3-ip FLC in the musculature have fibroblastic features and differ from fibroblasts commonly observed in connective tissues.
SK3-ip FLC showed a distinct morphology according to their location in the musculature. FLC in the circular and longitudinal muscle layers were bipolar with two main processes, FLC in the myenteric layer were multipolar with several processes, and FLC in the subserosal layer were multipolar with thin processes. FLC were observed to form cellular networks with their processes in each layer. The cellular communications of FLC were considered via gap junctions detected by electron microscopy (Komuro et al., 1999; Fujita et al., 2003) . The characteristic structure of FLC in the GI musculature was gap junctions with other cells of the same type or with smooth muscle cells. In contrast, there are no reports concerning gap junctions between FLC and ICC. Gap junctions in FLC were observed without remarkable changes in the GI musculatures of ICCdeficient c-kit mutant animals, such as the Ws/Ws rats (Ishikawa et al., 1997; Horiguchi and Komuro, 1998) and W/W v mice (Horiguchi and Komuro, 2000) . The fact that cellular communication occurs via gap junctions indicates that a network of FLC is electrically synchronized and that FLC communicate with smooth muscle cells in the GI musculature. The characteristic cellular network formed by the SK3-ip FLC would support cellular communication between FLC and with smooth muscle cells in the GI musculature.
Apamin, the selective blocker of SK channels, has been shown to affect the mechanical and electrical activity of the GI musculature such as inhibitory junctional potential and relaxation induced by the inhibitory motor neurons (De Man et al., 2003; Suzuki et al., 2003) . Therefore, apamin-sensitive SK channels are involved in the regulation of motility and electrical activity of the GI musculature. The specific expression of SK3 immunoreactivity in FLC suggests the regulatory role of FLC in the GI motility. SK3-ip FLC in the muscle layer were often observed in the vicinity of nerve fiber bundles, their long processes being often associated with intramuscular nerve fibers. Electron microscopic observations have shown a close relationship between FLC and nerve terminals (Komuro et al., 1999; Horiguchi and Komuro, 2000) . These morphological properties were the same as those observed between ICC and nerve terminals (Komuro et al., 1999; Iino and Horiguchi, 2006) . We previously observed that both FLC and ICC expressed nitric oxide-sensitive guanylate cyclase and were associated with nitric oxide-immunopositive nerve fibers and that ICC generated cGMP in response to nitric oxide (Iino et al., 2008 (Iino et al., , 2009b . Since nitric oxide signaling is an important inhibitory pathway in the GI musculature, FLC that contain guanylate cyclase immunoreactivity were believed to respond to nitric oxide derived from nerve terminals. These morphological features and molecular expressions of SK3-ip FLC strongly support the notion of their participation of these cells in the GI motility. In the subserosal layer, SK3-ip FLC were observed to be independent of enteric nerve fibers and to express specifically CD34 immunoreactivity. The CD34 expression of subserosal FLC and submucosal fibroblasts indicates that these two types of cells have common immunohistochemical features and similar functions. These findings suggest that subserosal FLC are a type of connective tissue fibroblast and maintain subserosal connective tissue.
In conclusion, our immunohistochemical observations indicated that FLC expressed both potassium channel protein SK3 and receptor tyrosine kinase PDGFR and were distributed in the circular and longitudinal muscle layers, myenteric layer, and subserosal layer throughout the murine GI tract (Table 1) . These cells had several long processes and often formed cellular networks with their processes. FLC were often associated with intramuscular nerve fibers and myenteric ganglia. We hypothesize that FLC realize cellular communication via gap junctions, are regulated by enteric nerves, and have a functional significance in the GI motility. 
